Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PORC (Postoperative Residual Curarization)”

5 trials

Showing 5 of 5 results

Not applicableStudy completedNCT01006720
What this trial is testing

Sugammadex and Neostigmine at Residual Neuromuscular Blockade

Who this might be right for
Residual Neuromuscular Block (TOF-ratio of 0.2)
Technical University of Munich 99
Post-approval studies (Phase 4)UnknownNCT01690338
What this trial is testing

Residual Curarization Incidence in China

Who this might be right for
Perioperative/Postoperative ComplicationsPORC (Postoperative Residual Curarization)
Peking University First Hospital 6,090
Not applicableUnknownNCT05040490
What this trial is testing

Influence of Neostigmine vs. Sugammadex on PORC and PPCs by Ultrasonography

Who this might be right for
Postoperative Pulmonary Complications
Peking Union Medical College Hospital 414
Post-approval studies (Phase 4)Study completedNCT01651572
What this trial is testing

Comparison Between Cisatracurium and Rocuronium in Terms of Recovery of the Muscular Strength in the Postoperative Phase After Surgery and General Anaesthesia

Who this might be right for
Postoperative Residual CurarizationResidual Neuromuscular Block
Azienda Ospedaliera di Padova 120
Post-approval studies (Phase 4)Study completedNCT00895609
What this trial is testing

Sugammadex and Neostigmine at Shallow Neuromuscular Blockade

Who this might be right for
Neuromuscular Block
Technical University of Munich 99

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation